Literature DB >> 3179963

Increasing incidence of primary brain lymphoma in the US.

N L Eby1, S Grufferman, C M Flannelly, S C Schold, F S Vogel, P C Burger.   

Abstract

There have been a number of clinical reports suggesting an increasing incidence of primary brain lymphoma unrelated to acquired immune deficiency syndrome (AIDS) and organ transplantation. To investigate this issue, the US incidence of this rare lymphoma was assessed using data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program (1973 through 1984). Never-married men, a relatively high risk group for AIDS, were excluded from the analyses. Brain lymphoma incidence increased from 2.7 in 1973 through 1975 to 7.5 cases per ten million population in 1982 through 1984 (chi-square trend, 15.25; P less than 0.001), and it increased among both men (chi-square trend, 6.74; P = 0.009) and women (chi-square trend, 10.48; P = 0.001). Increases in incidence also were observed among persons younger than 60 years of age (chi-square trend, 4.10; P = 0.04) and persons 60 years of age and older (chi-square trend, 9.16; P = 0.002). This increased incidence of brain lymphoma appears to be real: It antedates the AIDS epidemic and does not appear to be related to organ transplantation, another cause of increased risk of brain lymphoma. Although part of the increase may be an artifact of improvements in diagnostic technology and practice, most of the observed increase antedates the widespread use of such technologies. Finally, the increase in incidence of brain lymphoma does not appear to be related to overall trends in the incidence of brain tumors and non-Hodgkin's lymphoma, and it is not related to time trends in nosology.

Entities:  

Mesh:

Year:  1988        PMID: 3179963     DOI: 10.1002/1097-0142(19881201)62:11<2461::aid-cncr2820621135>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  75 in total

Review 1.  Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

Authors:  D F Nelson
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

2.  Primary pituitary lymphoma in an immunocompetent patient: a rare clinical entity.

Authors:  Yaxiong Li; Yuekang Zhang; Jianguo Xu; Ni Chen
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

3.  Primary central nervous system lymphoma imitates multiple sclerosis.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

4.  Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  S Morgello
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  An atypical cause of trigeminal neuralgia and panhypopituitarism.

Authors:  I Coulter; S Garrioch; A Toft
Journal:  Br J Radiol       Date:  2010-12       Impact factor: 3.039

6.  Primary Hypothalamic Lymphoma in an Adult Male: A Case Report and Literature Review.

Authors:  Humam Nisar Tanki; Khursheed Nayil Malik; Rumana Makhdoomi; Shaheen Feroz; Altaf Umaŕ Ramzan
Journal:  Oman Med J       Date:  2018-07

7.  Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.

Authors:  Zhuqing Li; Sankaranarayana P Mahesh; De Fen Shen; Baoying Liu; Willie O Siu; Frank S Hwang; Qing-Chen Wang; Chi-Chao Chan; Ira Pastan; Robert B Nussenblatt
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

8.  Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients.

Authors:  R Bashir; B McManus; C Cunningham; D Weisenburger; F Hochberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab.

Authors:  H Pels; H Schulz; O Manzke; E Hom; A Thall; A Engert
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.